Here are five trends:
1. Key factors contributing to its rapid growth include increasing geriatric population prone to chronic diseases as well as the increasing number of emergency cases.
2. In 2014, the North America inhalation anesthesia market accounted for nearly 43 percent of the total global revenue.
3. Asia Pacific is the fastest growing regional market.
4. The sevoflurane segment was the largest product group, accounting for over 70 percent of the demand in 2014. However, isoflurane is expected to witness nearly 12 percent growth from 2014 to 2022.
5. Key players in the market include Abbvie and Baxter.
More articles on anesthesia:
Anesthesiologist tops list of best paying jobs in the US: 3 takeaways
Children’s Healthcare of Atlanta PA in anesthesiology murdered in the Caribbean: 5 notes
7 common reasons anesthesiologists are involved in malpractice lawsuits
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.